Literature DB >> 9914589

Repeated antenatal corticosteroids: size at birth and subsequent development.

N P French1, R Hagan, S F Evans, M Godfrey, J P Newnham.   

Abstract

OBJECTIVE: The objective was to study the effects of repeated antenatal corticosteroids on birth size, growth, and development in preterm infants. STUDY
DESIGN: This observational study followed up for 3 years a prospective geographic cohort in the state of Western Australia of 477 singleton infants born at <33 weeks' gestation.
RESULTS: Birth weight ratio decreased with increasing number of corticosteroid courses (P =.001), and multivariate analyses confirmed a reduction in birth weight of as much as 9% (P =.014) and a reduction in head circumference of as much as 4% (P =.0024). There were no additional benefits in mortality or respiratory outcomes, and there was a trend toward more severe chronic lung disease. At age 3 years growth and severe disability outcomes did not appear to be related to increasing number of corticosteroid courses.
CONCLUSIONS: In this cohort study repeated corticosteroid courses were associated with adverse effects on size at birth without apparent benefits. These changes have the potential to affect later development.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9914589     DOI: 10.1016/s0002-9378(99)70160-2

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  100 in total

1.  Antenatal corticosteroids to prevent neonatal respiratory distress syndrome. We do not know whether repeated doses are better than a single dose.

Authors:  C Spencer; K Neales
Journal:  BMJ       Date:  2000-02-05

Review 2.  Fetal pharmacotherapy.

Authors:  Gideon Koren; Gil Klinger; Arne Ohlsson
Journal:  Drugs       Date:  2002       Impact factor: 9.546

3.  Intra-amniotic LPS and antenatal betamethasone: inflammation and maturation in preterm lamb lungs.

Authors:  Elke Kuypers; Jennifer J P Collins; Boris W Kramer; Gaston Ofman; Ilias Nitsos; J Jane Pillow; Graeme R Polglase; Matthew W Kemp; John P Newnham; Antonio W D Gavilanes; Relana Nowacki; Machiko Ikegami; Alan H Jobe; Suhas G Kallapur
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-12-09       Impact factor: 5.464

Review 4.  Potential programming of dopaminergic circuits by early life stress.

Authors:  Ana-João Rodrigues; Pedro Leão; Miguel Carvalho; Osborne F X Almeida; Nuno Sousa
Journal:  Psychopharmacology (Berl)       Date:  2010-11-19       Impact factor: 4.530

5.  The timing of prenatal exposure to maternal cortisol and psychosocial stress is associated with human infant cognitive development.

Authors:  Elysia P Davis; Curt A Sandman
Journal:  Child Dev       Date:  2010 Jan-Feb

6.  Cardiac effects of a single course of antenatal betamethasone in preterm infants.

Authors:  M Vural; I Yilmaz; F Oztunç; B Ilikkan; E Erginöz; Y Perk
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-12-06       Impact factor: 5.747

Review 7.  The management of preterm labour.

Authors:  Jayanta Chatterjee; Joanna Gullam; Manu Vatish; Steve Thornton
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2007-03       Impact factor: 5.747

Review 8.  Current perspectives on the prevention and management of chronic lung disease in preterm infants.

Authors:  Prakesh S Shah
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

9.  Multigenerational effects of fetal dexamethasone exposure on the hypothalamic-pituitary-adrenal axis of first- and second-generation female offspring.

Authors:  Nathan M Long; Stephen P Ford; Peter W Nathanielsz
Journal:  Am J Obstet Gynecol       Date:  2012-12-07       Impact factor: 8.661

Review 10.  Pregnancy outcomes in patients with autoimmune diseases and anti-Ro/SSA antibodies.

Authors:  Antonio Brucato; Rolando Cimaz; Roberto Caporali; Véronique Ramoni; Jill Buyon
Journal:  Clin Rev Allergy Immunol       Date:  2011-02       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.